The DOI matches its Crossref record.
Effects of Low Oral Doses of Melatonin, Given 2–4 Hours Before Habitual Bedtime, On Sleep in Normal Young Humans
Abstract
Low oral doses of melatonin raise serum melatonin concentrations to those normally occurring nocturnally and facilitate polysomnographically assessed sleep onset when given at different time points throughout the day, without altering mood or performance on the morning following treatment. In the present study, 12 young healthy volunteers, free of sleep disturbances, received 0.3 or 1.0 mg of melatonin or placebo at 2100 hours, 2-4 hours prior to their habitual bedtime. Polysomnographic recording of overnight sleep began at 2200 hours and continued until 0700 hours the following morning, when subjects were awakened. Sleep onset latency and latency to stage 2 sleep were significantly decreased as a result of melatonin treatment. Neither dose of melatonin significantly altered sleep architecture. Administration of the lower dose of melatonin (0.3 mg) at 2100 hours elevated serum melatonin to levels within the normal nocturnal range (113 +/- 13.5 pg/ml) at the time the sleep test was initiated. Neither melatonin dose caused "hangover effects", as assessed by self-reports or by mood and performance tests administered on the morning following treatment. These observations provide additional evidence that nocturnal melatonin secretion has a sleep-promoting function. They also indicate that an increase in serum melatonin concentrations, within the normal physiologic range, does not significantly alter sleep architecture in subjects with normal sleep who receive the treatment several hours prior to their habitual bedtime.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?
Fardet, A. (2010) · Nutrition Research Reviews · doi:10.1017/s0954422410000041 · Cited by 1,030
Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep
Cajochen, C., Kräuchi, K., & Wirz‐Justice, A. (2003) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2003.00989.x · Cited by 735
Melatonin as a Hormone: New Physiological and Clinical Insights
Cipolla-Neto, J., & Amaral, F. G. D. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00084 · Cited by 635
Human pineal physiology and functional significance of melatonin
Macchi, M. M., & Bruce, J. N. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.08.001 · Cited by 547
Effects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541
Self-citationNeurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist
Kato, K., Hirai, K., Nishiyama, K., Uchikawa, O., Fukatsu, K., Ohkawa, S., Kawamata, Y., Hinuma, S., & Miyamoto, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.007 · Cited by 539
Vitamin E: non-antioxidant roles
Azzi, A., & Stocker, A. (2000) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00006-0 · Cited by 488
Behavioral and neuroendocrine characteristics of the night-eating syndrome
Birketvedt, G. S. (1999) · JAMA · doi:10.1001/jama.282.7.657 · Cited by 433
Melatonin promotes sleep-like state in zebrafish
Zhdanova, I. V., Wang, S. Y., Leclair, O. U., & Danilova, N. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02444-1 · Cited by 418
Self-citationPhipps-Nelson, J., Redman, J. R., Dijk, D.-J., & Rajaratnam, S. M. W. (2003) · Sleep · doi:10.1093/sleep/26.6.695 · Cited by 394
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.005 · Cited by 393
Melatonin and sleep in aging population
Pandi-Perumal, S. R., Zisapel, N., Srinivasan, V., & Cardinali, D. P. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.08.009 · Cited by 369
Melatonin: From Basic Research to Cancer Treatment Clinics
Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.004 · Cited by 361
Melatonin and its analogs in insomnia and depression
Cardinali, D. P., Srinivasan, V., Brzezinski, A., & Brown, G. M. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00962.x · Cited by 353
VanSomeren, E. J. W. (2000) · Chronobiology International · doi:10.1081/cbi-100101050 · Cited by 329
Melatonin as a radioprotective agent: a review
Vijayalaxmi, Reiter, R. J., Tan, D.-X., Herman, T. S., & Thomas, C. R. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.02.006 · Cited by 303
Melatonin treatment for age-related insomnia
Zhdanova, I. V., Wurtman, R. J., Regan, M. M., Taylor, J. A., Shi, J. P., & Leclair, O. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7901 · Cited by 308
Unearthing the phylogenetic roots of sleep
Allada, R., & Siegel, J. M. (2008) · Current Biology · doi:10.1016/j.cub.2008.06.033 · Cited by 280
The assessment and management of insomnia: an update
Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019) · World Psychiatry · doi:10.1002/wps.20674 · Cited by 256
Vural, E. M. S., van Munster, B. C., & de Rooij, S. E. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0178-0 · Cited by 92
Randomized clinical trial of melatonin after night-shift work: Efficacy and neuropsychologic effects
Wright, S. W., Lawrence, L. M., Wrenn, K. D., Haynes, M. L., Welch, L. W., & Schlack, H. M. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70010-1 · Cited by 64
Acute effects of low doses of melatonin on the sleep of young healthy subjects
Pires, M. L. N., Benedito‐Silva, A. A., Pinto, L., Souza, L., Vismari, L., & Calil, H. M. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.310407.x · Cited by 35
Winkelman, J. W., Johnson, E. A., & Richards, L. M. (2011) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52006-7.00037-x · Cited by 33
Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial
Green, E. A., Black, B. K., Biaggioni, I., Paranjape, S. Y., Bagai, K., Shibao, C., Okoye, M. C., Dupont, W. D., Robertson, D., & Raj, S. R. (2014) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12067 · Cited by 33
Metadata
- Authors
- Zhdanova, I. V., Wurtman, R. J., Morabito, C., Piotrovska, V. R., & Lynch, H. J.
- Venue
- Sleep
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-07
- Volume
- 19
- Issue
- 5
- Pages
- 423-431
- ISSN
- 0161-8105 (ISSN-L)
- 1550-9109
- OpenAlex
- W198995741
- Cited by
- 224
- References
- 0
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.